French pharmaceutical company Ipsen is expanding its oncology research partnership with Marengo Therapeutics and will pay the group up to $1.2 billion for the use of its TriSTAR platform.
French pharmaceutical company Ipsen is expanding its oncology research partnership with Marengo Therapeutics and will pay the group up to $1.2 billion for the use of its TriSTAR platform.